Acquisition includes wholly owned subsidiary businesses BioKey BV and BioClue BV. Platform is based on a proprietary biological discovery called HYFT™ patterns, signature sequences in DNA, RNA, and ...
DIEPENBEEK, Belgium--(BUSINESS WIRE)--Diepe IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA) (TSXV: IPA) is pleased to share that IPA’s subsidiary Biostrand, a Belgian end-to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback